This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hennige, A. M. Articles by Kellerer, M. Search for Related Content PubMed PubMed Citation Articles by Hennige, A. M. Articles by Kellerer, M.

Inhibition of Ret Oncogene Activity by the Protein Tyrosine Phosphatase SHP1

Universität Tübingen (A.M.H., R.L., V.S., F.M., H.-U.H., M.K.), Medizinische Klinik und Poliklinik IV, D-72076 Tübingen, Germany; Institut für Hormon- und Fortpflanzungsforschung (W.H., D.A.), D-22529 Hamburg, Germany; Chirurgische Universitätsklinik (R.T.), D-72076 Tübingen, Germany; and Max-Planck-Institut für Biochemie (A.U.), D-82152 Martinsried, Germany

Address all correspondence and requests for reprints to: Dr. Monika Kellerer, University of Tübingen, Medizinische Klinik und Poliklinik IV, Otfried-Müller-Strasse 10, D-72076 Tübingen, Germany. E-mail: makellerer{at}med.uni-tuebingen.de

Germline mutations in the Ret protooncogene give rise to the inherited endocrine cancer syndromes MEN types 2A and 2B and familiar medullary thyroid carcinoma. Although it is well accepted that the constitutive active tyrosine kinase of Ret oncogenes ultimately leads to malignant transformation, it is not clear whether a decrease in the autophosphorylation of oncogenic Ret forms can affect the mitogenic and transforming activities of Ret. Potential modulators of the tyrosine kinase activity of Ret could be tyrosine phosphatases that are expressed in human thyroid tissue. Therefore, we investigated the impact of the tyrosine phosphatases SHP1 and SHP2 on the intrinsic tyrosine kinase activity and oncogenic potency of Ret with a 9-bp duplication in the cysteine-rich domain (codons 634–636), which was described in a patient with MEN type 2A recently. SHP1 and SHP2 were stably overexpressed in NIH3T3 fibroblasts together with Ret-9bp. Coexpression of SHP1 with Ret-9bp reduced the autophosphorylation of Ret-9bp by 19 ± 7% (P = 0.01, n = 4), whereas no effect was seen with SHP2. Furthermore, Ret-9bp could be coimmunoprecipitated with SHP1 but not with SHP2 antibodies. Suppression of the Ret-9bp tyrosine kinase activity by SHP1 caused a decrease in activation of Erk2 (extracellular signal-regulated kinase) and abolished PKB/Akt (protein kinase B) phosphorylation. In addition, diminished Ret-9bp autophosphorylation led to reduced phosphorylation of the transcription factor jun-D. Finally, the inhibitory effect on Ret-9bp signaling resulted in a 40–60% reduction of [³H]thymidine incorporation and in reduced ability of NIH3T3 cells to form colonies in soft agar. In conclusion, the data suggest that SHP1 caused a moderate reduction of Ret autophosphorylation, which led to a strong suppression of the Ret oncogene activity.

This article has been cited by other articles:

				F. Ledda, O. Bieraugel, S. S. Fard, M. Vilar, and G. Paratcha Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF J. Neurosci., January 2, 2008; 28(1): 39 - 49. [Abstract] [Full Text] [PDF]

				J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors Endocr. Rev., August 1, 2006; 27(5): 535 - 560. [Abstract] [Full Text] [PDF]

				M. C. Zatelli, D. Piccin, F. Tagliati, A. Bottoni, A. Luchin, and E. C. degli Uberti Src Homology-2-Containing Protein Tyrosine Phosphatase-1 Restrains Cell Proliferation in Human Medullary Thyroid Carcinoma Endocrinology, June 1, 2005; 146(6): 2692 - 2698. [Abstract] [Full Text] [PDF]

				E. Roccato, C. Miranda, G. Raho, S. Pagliardini, M. A. Pierotti, and A. Greco Analysis of SHP-1-mediated Down-regulation of the TRK-T3 Oncoprotein Identifies Trk-fused Gene (TFG) as a Novel SHP-1-interacting Protein J. Biol. Chem., February 4, 2005; 280(5): 3382 - 3389. [Abstract] [Full Text] [PDF]

				M. Drosten, G. Hilken, M. Bockmann, F. Rodicker, N. Mise, A. N. Cranston, U. Dahmen, B. A. J. Ponder, and B. M. Putzer Role of MEN2A-Derived RET in Maintenance and Proliferation of Medullary Thyroid Carcinoma J Natl Cancer Inst, August 18, 2004; 96(16): 1231 - 1239. [Abstract] [Full Text] [PDF]

				A. D'Alessio, D. Califano, M. Incoronato, G. Santelli, T. Florio, G. Schettini, M. S. Carlomagno, L. Cerchia, and V. de Franciscis The Tyrosine Phosphatase Shp-2 Mediates Intracellular Signaling Initiated by Ret Mutants Endocrinology, October 1, 2003; 144(10): 4298 - 4305. [Abstract] [Full Text] [PDF]